iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference

Rhea-AI Summary

iTeos Therapeutics, Inc. (ITOS) will participate in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference in New York City on November 28, 2023. The company focuses on immune-oncology therapeutics for patients.

WATERTOWN, Mass. and GOSSELIES, Belgium, Nov. 21, 2023 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immune-oncology therapeutics for patients, today announced that management will participate in a fireside chat at the upcoming Piper Sandler 35^th Annual Healthcare Conference in New York City on Tuesday, November 28, 2023 at 1:30 p.m. ET.

A live webcast of the event will be available on the Investor section of the Company’s website at https://www.iteostherapeutics.com. An archived replay will be available for approximately 30 days following the presentation.

About iTeos Therapeutics, Inc.

iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of tumor immunology and immunosuppressive pathways to design novel product candidates with the potential to restore the immune response against cancer. The Company’s innovative pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways designed with optimized pharmacologic properties for improved clinical outcomes, including the TIGIT:CD226 axis and the adenosine pathway. iTeos Therapeutics is headquartered in Watertown, MA with a research center in Gosselies, Belgium.

Internet Posting of Information

iTeos Therapeutics routinely posts information that may be important to investors in the 'Investors' section of its website at www.iteostherapeutics.com. The company encourages investors and potential investors to consult our website regularly for important information about iTeos Therapeutics.

For further information, please contact:

Investor Contact:

Carl Mauch
iTeos Therapeutics, Inc.
carl.mauch@iteostherapeutics.com

Media Contact:

media@iteostherapeutics.com

FAQ

What is the upcoming event iTeos Therapeutics, Inc. (ITOS) will participate in?

iTeos Therapeutics, Inc. (ITOS) will participate in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference in New York City on November 28, 2023.

What is the focus of iTeos Therapeutics, Inc. (ITOS)?

iTeos Therapeutics, Inc. (ITOS) focuses on the discovery and development of a new generation of immune-oncology therapeutics for patients.

Where can I watch the live webcast of the event?

A live webcast of the event will be available on the Investor section of the Company’s website at https://www.iteostherapeutics.com.

How long will the archived replay of the event be available?

An archived replay will be available for approximately 30 days following the presentation.